C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 5/08 (2006.01) A61K 38/06 (2006.01) A61K 38/07 (2006.01) A61K 38/08 (2006.01) A61P 31/14 (2006.01) C07K 5/10 (2006.01) C07K 7/06 (2006.01)
Patent
CA 2615896
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections. Formula (I).
La présente invention concerne des composés macrocycliques de formule (I) qui sont utiles en tant qu~inhibiteurs de la protéase NS3 du virus de l~hépatite C (VHC) ainsi que leur synthèse et leur utilisation pour le traitement ou la prévention des infections par le VHC Formule (I).
Holloway M. Katharine
Liverton Nigel J.
Ludmerer Steven W.
Mccauley John A.
Olsen David B.
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
LandOfFree
Macrocyclic peptides as hcv ns3 protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Macrocyclic peptides as hcv ns3 protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrocyclic peptides as hcv ns3 protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1881936